Optimizing Treatment for Older Patients With HR+ Low-Risk Breast Cancer

(MedPage Today) -- The time has come to revisit the practice of omitting adjuvant radiotherapy (RT) for older patients with early hormone receptor (HR)-positive breast cancer and instead consider a more individualized approach to RT and hormonal...